Europe Medical Aesthetics Market Size, Share & Growth Forecast 2024-2031 (US$ 3.8B in 2022 to US$ 8.38B by 2030)

Market Size and Growth

The Europe Medical Aesthetics Market was valued at US$ 3.8 billion in 2022 and is projected to reach US$ 8.38 billion by 2030, growing at a CAGR of 10.4% during the forecast period 2023-2030. The growth is driven by increasing consumer demand for non-invasive cosmetic procedures, rising awareness of aesthetic treatments, technological advancements in devices and products, and expanding adoption among both clinics and individual users.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/europe-medical-aesthetics-market?juli

Recent Industry Developments

United States
✅ In July 2025, Hologic, Inc. introduced a non‐invasive skin‐tightening radio‐frequency device in Massachusetts, designed for facial and body contouring.

✅In June 2025, Cutera, Inc. completed clinical trials for a laser‐based body‐contouring and skin‐resurfacing system in California, demonstrating improved safety and efficacy.

✅Regulatory attention increased: Alerts around unlicensed cosmetic‐treatment providers grew nationally, with authorities warning about counterfeit injectable products and loose oversight of some med‐spa operations.

Japan
✅In September 2025, Shiseido Co., Ltd. launched an AI‐powered skin‐analysis and treatment‐planning platform in Tokyo, combining imaging, deep learning and targeted aesthetic therapies.

✅In August 2025, Hugel Japan Co., Ltd. invested to expand production and R&D of dermal fillers and botulinum‐toxin treatments in Osaka, aiming to launch next‐gen injectable solutions.

✅In July 2025, MediTox Inc. introduced a novel botulinum‐based aesthetic therapy in Kyoto designed for facial wrinkle reduction and muscle relaxation, offering longer‐lasting effects with fewer side‐effects.

These developments highlight how both countries are accelerating innovation in non‐invasive procedures, digital tools, and device/therapy manufacturing, setting the stage for continued growth in the medical aesthetics market.

Market Segmentation

By Product
Skin Tightening Devices: Equipment and systems (e.g., radio‐frequency, ultrasound) used to firm and lift skin by stimulating collagen and elastin.

Facial Aesthetic Devices: Devices specifically designed for facial cosmetic treatments, including injectables, micro‐needling systems, and facial contouring tools.

Aesthetic Lasers: Laser systems used for cosmetic treatments like skin rejuvenation, hair removal, tattoo removal, and resurfacing.

Body Contouring Devices: Non‐surgical and minimally invasive equipment (e.g., cryolipolysis, electromagnetic, radio‐frequency) for shaping and reducing body fat and cellulite.

Facial Implants: Surgical or semi‐surgical implantable materials used for aesthetic facial structure enhancement (e.g., chin, cheeks) and long‐term facial contouring.

By Application
Carbon Peel: A cosmetic procedure using carbon lotion followed by laser to exfoliate and cleanse skin, often combined with laser treatments.

Tattoo Removal: Use of laser and other technologies to remove or lighten tattoos as part of aesthetic services.

Skin Resurfacing: Treatments (laser, chemical peel, dermabrasion) aimed at improving skin texture, reducing wrinkles, scars, and pigmentation.

Hair Removal: Permanent or semi‐permanent removal of unwanted body or facial hair using lasers, intense pulsed light (IPL), or electrolysis devices.

Scar Treatment: Aesthetic therapies aimed at reducing visibility of scars (acne, surgery, trauma) using lasers, micro‐needling, or implantable devices.

Others: Other aesthetic applications not listed above such as cellulite reduction, stretch‐mark treatments, vein treatments, or other emerging procedures.

By End‐User
Hospitals: Large healthcare institutions offering aesthetic services alongside medical care, often equipped with advanced devices and staffed with specialists.

Dermatology Clinics: Specialized clinics focusing on skin health and aesthetics, offering treatments for skin, hair, and cosmetic dermatology.

Medical Spas: Facilities offering advanced aesthetic treatments in a spa‐like environment under medical supervision often mid‐to‐high end.

Beauty Centers: Non‐medical aesthetic facilities (but with regulated device use) offering cosmetic and beauty treatments, including some aesthetic device treatments.

By Country (Europe)
Germany
United Kingdom (U.K.)
France
Italy
Spain
Rest of Europe (all other European countries not listed above)
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=europe-medical-aesthetics-market

Key Player

1. AbbVie Inc. (including Allergan Inc.)
Overview & Financials:
AbbVie reported full‐year net revenues of approximately US$ 56.3 billion in 2024. A subset of that, the "Aesthetics" business, accounted for US$ 1.30 billion in Q4 2024 (US$ 839 million U.S. + US$ 459 million international) indicating the aesthetics segment continues to play a meaningful role in its broad portfolio.

Product & Market Focus:
Under the Allergan banner, AbbVie offers major aesthetic brands and devices injectables (e.g., botulinum‐toxin products, dermal fillers), and complementary systems targeting aesthetic treatments. This anchors their positioning in both surgical and non‐invasive aesthetic care.

Strategic Positioning:
As a large global pharma‐aesthetics player, AbbVie leverages deep R&D, broad global reach, and trusted brand equity. While the aesthetics segment is smaller relative to its core therapeutic businesses, the company is well‐positioned to cross‐leverage aesthetic and therapeutic dermatology offerings.

2. Johnson & Johnson
Overview & Financials:
Johnson & Johnson is one of the largest diversified healthcare companies globally, with total revenues exceeding tens of billions of dollars annually.

Product & Market Focus:
In the aesthetic segment, J&J offers energy‐based aesthetic devices, injectable treatments, and aesthetic consumables under its various dermatology and medical‐device businesses.

Strategic Positioning:
J&J's strong presence across surgical, cosmetic, and device markets enables it to integrate aesthetic offerings with broader hospital/clinic‐based systems, giving it an advantage in institutional adoption and full‐service offerings.

3. Cutera Inc.
Overview & Financials:
Cutera reported full‐year 2023 revenue of approximately US$ 212.4 million and Q2 2024 revenue of US$ 34.4 million, with full‐year 2024 guidance in the range of US$ 140‐145 million.

Product & Market Focus:
Cutera develops a portfolio of energy‐based aesthetic devices, lasers and light systems for treatments such as hair removal, skin resurfacing, body‐contouring, and tattoo removal. Examples include the "AviClear" acne‐laser system and other capital devices aimed at dermatologists and aesthetic clinics.

Strategic Positioning:
As a specialist device company, Cutera occupies a niche in the capital‐equipment side of aesthetic treatment. While smaller than large platform players, it focuses on growth through high‐tech device launches and international expansion.

4. Alma Lasers
Overview & Financials:
Alma Lasers, a leader in aesthetic medical‐device solutions, operates globally with a portfolio of lasers, radio‐frequency systems and body‐contouring technologies. (Exact recent revenue publicly broken‐down for aesthetics only is limited.)

Product & Market Focus:
Alma offers devices covering facial aesthetic treatments, skin tightening, body contouring, and hair removal spanning the major product segments in medical aesthetics.

Strategic Positioning:
Its strength lies in multi‐application platforms and global distribution, enabling it to address the evolving needs of dermatologists and med‐spas across regions.

5. Merz Pharma
Overview & Financials:
Merz Pharma is a major privately‐held company specializing in aesthetic medicine and neurology. While full global revenues are not as widely publicised as listed firms, the company is known for strong performance in aesthetic injectables and devices.

Product & Market Focus:
Merz's aesthetic offerings include dermal fillers, neurotoxins, skin‐rejuvenation devices, and complementary product lines focused on aesthetic dermatology.

Strategic Positioning:
Merz combines therapeutic and aesthetic platforms which enables it to serve both medical and cosmetic skin markets and is recognized for innovation and premium positioning in the aesthetics space.

Regional Insights Europe Medical Aesthetics Market:
Germany: Holds a significant share in the European medical aesthetics market due to advanced healthcare infrastructure, high disposable income, and strong adoption of innovative aesthetic technologies. The government's favorable regulations and support for medical devices boost market growth.

U.K.: The market is driven by growing consumer awareness, rising demand for non-invasive procedures, and expansion of dermatology clinics and medical spas.

France & Italy: These countries see steady growth due to increasing preference for minimally invasive procedures and rising beauty consciousness among consumers.

Spain & Rest of Europe: Emerging markets with expanding medical aesthetics services and gradual adoption of high-tech devices contribute to overall regional growth.

Key Drivers: Technological advancements, growing demand for cosmetic procedures, rising disposable income, and supportive regulatory frameworks are fueling growth across Europe.

Get Customized Report as per your Business Requirements: https://www.datamintelligence.com/customize/europe-medical-aesthetics-market?juli

Conclusion

The Europe Medical Aesthetics Market is poised for robust growth, driven by rising demand for non-invasive procedures, technological innovations, and increasing awareness of cosmetic treatments. Key players like AbbVie, Johnson & Johnson, Cutera, Alma Lasers, and Merz Pharma are leveraging advanced devices, injectables, and multi-application platforms to capture market share. Large diversified companies benefit from global reach and brand trust, while specialist device firms focus on innovation and high-tech solutions. With the growing preference for minimally invasive treatments, strategic investments in R&D, and expansion across dermatology clinics, medical spas, and hospitals, stakeholders are well-positioned to capitalize on the expanding market opportunities in Europe.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?jk

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.